These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS. Ohashi Y, Hirayama A, Ishikawa T, Nakamura S, Shimizu K, Ueno Y, Tomita M, Soga T. Mol Biosyst; 2008 Feb; 4(2):135-47. PubMed ID: 18213407 [Abstract] [Full Text] [Related]
6. CE-MS in metabolomics. Ramautar R, Somsen GW, de Jong GJ. Electrophoresis; 2009 Jan; 30(1):276-91. PubMed ID: 19107702 [Abstract] [Full Text] [Related]
7. Is metabolomics reachable? Different purification strategies of human colon cancer cells provide different CE-MS metabolite profiles. Simó C, Ibáñez C, Gómez-Martínez A, Ferragut JA, Cifuentes A. Electrophoresis; 2011 Jun; 32(13):1765-77. PubMed ID: 21626520 [Abstract] [Full Text] [Related]
17. Challenges and developments in tandem mass spectrometry based clinical metabolomics. Ceglarek U, Leichtle A, Brügel M, Kortz L, Brauer R, Bresler K, Thiery J, Fiedler GM. Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):266-71. PubMed ID: 19007853 [Abstract] [Full Text] [Related]
18. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells. Tolstikov V, Nikolayev A, Dong S, Zhao G, Kuo MS. PLoS One; 2014 Mar 25; 9(12):e114019. PubMed ID: 25486521 [Abstract] [Full Text] [Related]